Skip to main content

Peer Review reports

From: A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

Original Submission
18 Nov 2009 Submitted Original manuscript
18 Nov 2009 Author responded Author comments - Helena Linardou
Resubmission - Version 2
18 Nov 2009 Submitted Manuscript version 2
7 Jan 2010 Editorially accepted
7 Jan 2010 Article published 10.1186/1741-7015-8-3

You can find further information about peer review here.

Back to article page